Early changes can signal that the current medication plan needs to be reassessed, including:
These changes do not necessarily mean that every medication needs a new route. They are signals to look ahead. Waiting until the patient can no longer take medications can leave the team and caregiver trying to make route changes during an acute symptom crisis.
Early recognition creates an opportunity to simplify the medication regimen, confirm what the patient and caregiver can realistically administer, and arrange medications or supplies before they are urgently needed.
When swallowing becomes difficult, the hospice team will evaluate which medications remain necessary based on their expected benefit, the patient’s goals of care, and the current symptom burden.
A medication review can help the team:
Deprescribing should be deliberate. Some medications can be stopped safely, while others require tapering or substitution to prevent rebound symptoms.
The goal is not to preserve every medication. It is to preserve comfort with the simplest reliable regimen.
Some tablets can be crushed and mixed with a small amount of food or liquid, but crushing should be evaluated medication by medication.
Modified-release, extended-release, delayed-release, enteric-coated, and certain specialty formulations should not be crushed unless a pharmacist confirms it is appropriate. Altering these products can change release characteristics, absorption, effectiveness, or tolerability.
Even when crushing is technically acceptable, it may not always fit the plan. The powder may taste unpleasant, require too much food or liquid, or still depend on the patient’s ability to swallow safely.
A liquid medication can be easier to administer than a tablet, but it is still an oral medication unless it is specifically designed and demonstrated to work through another route.
Before using a liquid, consider whether the patient can manage it safely, whether the dose volume is realistic, whether a concentrated product is available, and whether the medication requires swallowing to work.
“Sublingual” is also often used broadly in hospice care. However, placing a medication under the tongue does not guarantee reliable absorption through the oral mucosa. Absorption depends on the medication, formulation, dose volume, contact time, oral moisture, secretions, and patient condition.
Some medications commonly given sublingually may rely substantially on swallowing rather than transmucosal absorption. Research involving sublingual administration of medications has found limited and variable transmucosal absorption of certain medications.
When a patient cannot manage medication in the mouth, control secretions, swallow reliably, or tolerate placement, the oral cavity may no longer provide dependable symptom relief.
When oral administration is no longer safe, practical, or reliable, the hospice team may consider another route. The right option depends on the medication, symptom urgency, patient condition, caregiver capacity, availability, and goals of care.
The key question is not simply whether the patient can swallow. It is whether the medication can be delivered reliably, quickly enough, and simply enough to support comfort.
Hospice pharmacists help ensure the medication plan remains workable as a patient’s condition changes. They can help the interdisciplinary team:
Pharmacists can help connect the medication, formulation, route, administration, absorption, access, and goals of care to identify the most practical way to deliver needed medications.
When a patient’s ability to take medications changes:
At the end of life, medication management is not only about choosing the right drug. It is about whether the patient can receive it, whether it will work through the selected route, and whether administration supports rather than disrupts comfort.
BetterRX is The Better Way to Manage Hospice Medications. Hospice teams get hospice medication management software, a Custom Tailored Pharmacy Alliance, and On-Demand PharmD Access to help adapt medication plans as patient needs change.
Support includes in-depth formulary guidance and patient-specific consultations on formulation and route selection, including questions about crushing, opening, splitting, and other medication manipulation. Patient-Level Clinical Reviews help identify evidence-supported deprescribing opportunities.
At the end of life, good medication management means adapting the plan as changes occur so comfort remains at the center of care.